Cite
Mid-treatment Ultrasound Descriptors as Qualitative Imaging Biomarkers of Pathologic Complete Response in Patients with Triple-Negative Breast Cancer
MLA
Rosalind P. Candelaria, et al. “Mid-Treatment Ultrasound Descriptors as Qualitative Imaging Biomarkers of Pathologic Complete Response in Patients with Triple-Negative Breast Cancer.” Ultrasound in Medicine & Biology, vol. 48, June 2022, pp. 1010–18. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5d02c6555dbe3f76614be9de6b1029d6&authtype=sso&custid=ns315887.
APA
Rosalind P. Candelaria, Beatriz E. Adrada, Deanna L. Lane, Gaiane M. Rauch, Stacy L. Moulder, Alastair M. Thompson, Roland L. Bassett, Elsa M. Arribas, Huong T. Le-Petross, Jessica W.T. Leung, David A. Spak, Elizabeth E. Ravenberg, Jason B. White, Vicente Valero, & Wei T. Yang. (2022). Mid-treatment Ultrasound Descriptors as Qualitative Imaging Biomarkers of Pathologic Complete Response in Patients with Triple-Negative Breast Cancer. Ultrasound in Medicine & Biology, 48, 1010–1018.
Chicago
Rosalind P. Candelaria, Beatriz E. Adrada, Deanna L. Lane, Gaiane M. Rauch, Stacy L. Moulder, Alastair M. Thompson, Roland L. Bassett, et al. 2022. “Mid-Treatment Ultrasound Descriptors as Qualitative Imaging Biomarkers of Pathologic Complete Response in Patients with Triple-Negative Breast Cancer.” Ultrasound in Medicine & Biology 48 (June): 1010–18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....5d02c6555dbe3f76614be9de6b1029d6&authtype=sso&custid=ns315887.